Ticker Details
Xilio Therapeutics, Inc. Common Stock
IPO Date:	October 18, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$41.87M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.19 | 4.87%
Avg Daily Range (30 D):	$0.02 | 2.48%
Avg Daily Range (90 D):	$0.02 | 2.54%

Institutional Daily Volume
Avg Daily Volume:	.49M
Avg Daily Volume (30 D):	.47M
Avg Daily Volume (90 D):	.57M

Trade Size
Avg Trade Size (Sh.):	336
Avg Trade Size (Sh.) (30 D):	633
Avg Trade Size (Sh.) (90 D):	495

Institutional Trades
Total Institutional Trades:	18
Avg Institutional Trade:	$2.05M
Avg Institutional Trade (30 D):	$.53M
Avg Institutional Trade (90 D):	$.53M
Avg Institutional Trade Volume:	.68M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.69M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	597.56K

News

Feb 12, 2026 @ 2:34 AM Xilio Therapeutics Announces Pricing of Underwritt... Source: Not Specified

Oct 3, 2025 @ 1:00 PM Xilio Therapeutics Announces Upcoming Presentation... Source: Xilio Therapeutics

Jun 5, 2025 @ 10:38 PM Xilio Therapeutics Announces Closing of $50.0 Mill... Source: N/A

Jun 2, 2025 @ 10:11 AM Xilio Therapeutics Announces Proposed Public Offer... Source: Globe Newswire

May 31, 2025 @ 12:00 PM Xilio Therapeutics Announces Updated Phase 2 Data ... Source: N/A

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.61	$-.11	$-.16
Diluted EPS	$-.61	$-.11	$-.16
Revenue	$31.8M	$19.07M	$8.08M
Gross Profit
Net Income / Loss	$-58.49M	$-16.29M	$-15.84M
Operating Income / Loss	$-43.78M	$-1.93M	$-14.37M
Cost of Revenue
Net Cash Flow	$42.53M	$-17.78M	$32.48M
PE Ratio